EUTECNIQ Sciences

See every page on one mapArrow keys move through results · Enter opens · Esc closes

Flagship application · proposed

LBM Regulatory Intelligence: from botanical candidate to a defensible safety dossier.

Many botanicals used elsewhere in the world may be new dietary ingredients under U.S. law, depending on their identity, history, manufacturing and intended use. EUTECNIQ proposes to help companies work out which pathway applies, what evidence is missing, and which studies are worth running, then assemble a traceable dossier with qualified experts, laboratories and CROs.

DemonstrationThe screening rules below come from the statute, 21 CFR 190.6 and FDA guidance, as cited. No model is trained, no client exists and no notification has been prepared. This is not legal advice; FDA does not approve notifications.

01 · The workflow

Ten steps from candidate to dossier, each with an owner.

Models assist evidence synthesis, gap ranking and study planning. People decide: qualified laboratories and CROs produce the measurements, toxicologists and counsel review the conclusions.

  1. Botanical identity and authenticity

    Confirm the species, part and preparation against authenticated material; flag known adulterants.

    Partner laboratory · model-assisted review

  2. Ingredient history and eligibility

    Pre-1994 marketing, food-supply history, chemical alteration and the drug exclusion, each answer cited.

    EUTECNIQ · counsel confirms

  3. Chemical and compositional characterization

    Markers, fingerprints and batch consistency, with methods fit for the material.

    Partner laboratory

  4. Manufacturing-process definition

    Flowchart, solvents, ratio and controls, so the notified ingredient is the one that will be made.

    EUTECNIQ with the manufacturer

  5. Contaminant and adulteration risk

    Elements, pesticides, mycotoxins, microbes, residual solvents, ranked by source and process.

    Model-assisted · partner laboratory

  6. Toxicological evidence review

    Systematic, traceable review of published toxicology and human data, with study quality appraised.

    EUTECNIQ · toxicologist reviews

  7. Exposure and intended use

    Serving, frequency, duration and population against documented history: the exposure gap.

    EUTECNIQ

  8. Identification of data gaps

    Every missing or partial piece of evidence, mapped to the guidance section that asks for it.

    EUTECNIQ

  9. Prioritization of studies

    Cheapest decisive questions first; studies only where the gap and the literature require them.

    EUTECNIQ · CROs run studies

  10. Traceable dossier and expert review

    Safety narrative and calculations with every source linked, reviewed by experts and counsel before filing.

    EUTECNIQ · experts · counsel

02 · Demonstration

Screen a candidate: pathway, exposure gap, data gaps and a plan.

Load a hypothetical worked example or answer the questions yourself. The result updates as you go.

Rules: 21 U.S.C. 321(ff) and 350b(a), (d); 21 CFR 190.6; FDA final guidance, NDI notification procedures and timeframes (March 2024); FDA final guidance, NDI identity and safety information (October 2026), Sections VI, VII and Appendix A (Standard Safety Testing Table); FDA draft guidance (2016, revised October 2026) for when a notification is needed. Examples A, B and C are hypothetical and name no plant. Educational demonstration; legal conclusions belong with counsel.

03 · Inside the platform

Where the models would help, and where they cannot.

Evidence synthesis

Every claim linked to its source

Literature and records extracted into the knowledge graph with citations kept, so a reviewer can check each statement.

Exposure

The exposure gap, computed

Historical against proposed intake, including other sources, feeding the safety calculations FDA’s guidance describes.

Risk

Contaminant and adulteration ranking

Hazards ranked by species, origin and process, so testing goes where the risk is.

Planning

Studies ranked by what they decide

Avoidable studies identified with a documented rationale; required studies are never skipped.

What it cannot do. A model does not replace a required toxicology study; FDA’s guidance says in vitro and in silico methods are unlikely to be sufficient on their own. FDA does not approve notifications, and an acknowledgment without objection is not an FDA safety finding. No result guarantees FDA’s response.

04 · Who it is for

Suppliers, brands and manufacturers bringing a botanical to the U.S. market.

First

International botanical suppliers

Seeking U.S. market entry for an ingredient with use elsewhere, and a dossier they can own or reference.

First

U.S. brands and ingredient distributors

Evaluating a new botanical before they commit to a supplier or a launch.

First

Manufacturers

Needing standardization, formulation and evidence packages for a defined ingredient.

Later

Pharmaceutical and cosmetic developers

Needing ingredient intelligence under their own regulatory pathways.

The buyer pays for a decision and an evidence-backed development path, not another stand-alone test report. Engagements would start as fixed-scope feasibility work. None is available yet.

Health information notice. These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease, and nothing here is medical advice.

Read the full notice

The information is for general education only. It does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed. Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to start a development project?

Tell us about an ingredient you want to specify, verify or license. Questions? Email [email protected]